Advertisement

Topics

NexMed Company Profile

16:44 EST 19th November 2017 | BioPortfolio

NexMed is an innovative drug developer that is leveraging its proprietary NexACT® drug delivery technology to produce a host of new medical treatments. NexMed’s drugs address a variety of health conditions, such as nail fungus, arthritis, sexual disorders and more. NexMed offers large pharmaceutical companies the opportunity to incorporate NexACT® into their existing drugs, allowing these companies to save considerably on R&D costs while developing new patient-friendly transdermal products and extending patent lifespans and brand equity. NexMed has also made significant strides with its proprietary anti-fungal drug, NM10060. In September of 2005, the Company announced a partnership with Novartis International Pharmaceutical Ltd. for the licensing and marketing NM10060. Other leading treatments under development include Alprox-TD for the treatment of erectile dysfunction, Femprox, a topical cream cure for female sexual dysfunction. NexMed’s drugs incorporate NexACT® drug delivery technology which offers several competitive advantages in the treatment of various illnesses including: fast onset of action, patient friendly route of delivery, little or no side effects and improved clinical efficacy. The NexACT® penetration enhancers are designed to be structurally similar to and biologically compatible with the skin structure, are non-toxic, biodegradable, and enable drug candidates to efficiently overcome the skin or mucosal membranes. NexMed’s NexACT technology has wide-ranging applicability in the development of transdermal dosage forms such as patches, creams, gels, ointments, lotions, solutions and intranasal sprays.

Location

89 Twin Rivers Drive
East Windsor
NJ
08520
United States of America

Contact

Phone: (609) 371-8123
Fax: (609) 426-9116
Email: ccantwell@rubensteinir.com


News Articles [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [4 Associated Companies listed on BioPortfolio]

NexMed, Inc.

NexMed is the largest specialty CRO based in San Diego, CA and is one of the industry's most experienced CROs for in vitro and in vivo pharmacology services and research models. T...

NexMed

NexMed is an innovative drug developer that is leveraging its proprietary NexACT® drug delivery technology to produce a host of new medical treatments. NexMed’s drugs address a variety of health co...

Apricus Biosciences

Backed by NexMed, USA and Bio-Quant, Inc., its revenue generating CRO business, Apricus Bio has leveraged the flexibility of its proven NexACT® drug delivery technology to enab...

Apricus Biosciences, Inc.

Backed by NexMed, USA and Bio-Quant, Inc., its revenue generating CRO business, Apricus Bio has leveraged the flexibility of its proven NexACT® drug delivery technology to enab...

More Information about "NexMed" on BioPortfolio

We have published hundreds of NexMed news stories on BioPortfolio along with dozens of NexMed Clinical Trials and PubMed Articles about NexMed for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NexMed Companies in our database. You can also find out about relevant NexMed Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record